These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacodynamic Effects of Switching From Prasugrel to Ticagrelor: Results of the Prospective, Randomized SWAP-3 Study. Franchi F; Faz GT; Rollini F; Park Y; Cho JR; Thano E; Hu J; Kureti M; Aggarwal N; Durairaj A; Been L; Zenni MM; Guzman LA; Suryadevara S; Antoun P; Bass TA; Angiolillo DJ JACC Cardiovasc Interv; 2016 Jun; 9(11):1089-98. PubMed ID: 27013060 [TBL] [Abstract][Full Text] [Related]
23. How Long Does It Take for Clopidogrel and Ticagrelor to Inhibit Platelets in Patients Undergoing Primary Percutaneous Coronary Intervention? A Detailed Pharmacodynamic Analysis: Time Course of Platelet Reactivity in STEMI (TOPS). Bergmeijer TO; Godschalk TC; Janssen PWA; Berge KVD; Breet NJ; Kelder JC; Hackeng CM; Ten Berg JM Semin Thromb Hemost; 2017 Jun; 43(4):439-446. PubMed ID: 28561235 [TBL] [Abstract][Full Text] [Related]
24. Aspirin withdrawal in patients treated with ticagrelor presenting with non-ST elevation myocardial infarction. Beigel R; Mazin I; Koifman E; Shechter M; Pres H; Shlomo N; Rosenberg N; Asher E; Matetzky S J Thromb Haemost; 2018 Apr; 16(4):663-669. PubMed ID: 29443445 [TBL] [Abstract][Full Text] [Related]
25. Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction. Lee YS; Jin CD; Kim MH; Guo LZ; Cho YR; Park K; Park JS; Park TH; Kim YD Circ J; 2015; 79(6):1248-54. PubMed ID: 25959558 [TBL] [Abstract][Full Text] [Related]
26. Platelet inhibition with standard vs. lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study. Kubica J; Adamski P; Buszko K; Barańska M; Sikora J; Marszałł MP; Sobczak P; Sikora A; Kuliczkowski W; Fabiszak T; Kubica A; Jilma B; Alexopoulos D; Navarese EP Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):139-148. PubMed ID: 30689800 [TBL] [Abstract][Full Text] [Related]
28. Superiority of ticagrelor over clopidogrel in patients after cardiac arrest undergoing therapeutic hypothermia. Moudgil R; Al-Turbak H; Osborne C; Hibbert B; So DY; Le May MR; Can J Cardiol; 2014 Nov; 30(11):1396-9. PubMed ID: 25442437 [TBL] [Abstract][Full Text] [Related]
29. Chewing versus Swallowing Ticagrelor to Accelerate Platelet Inhibition in Acute Coronary Syndrome - the CHEERS study. For The PLATIS (Platelets and Thrombosis in Sheba) Study Group. Asher E; Frydman S; Katz M; Regev E; Sabbag A; Mazin I; Abu-Much A; Kukuy A; Mazo A; Erez A; Berkovitch A; Narodistky M; Barbash I; Segev A; Beigel R; Matetzky S Thromb Haemost; 2017 Apr; 117(4):727-733. PubMed ID: 28150850 [TBL] [Abstract][Full Text] [Related]
30. Comparison of platelet inhibition by prasugrel versus ticagrelor over time in patients with acute myocardial infarction. Perl L; Zemer-Wassercug N; Rechavia E; Vaduganathan M; Orvin K; Weissler-Snir A; Lerman-Shivek H; Kornowski R; Lev EI J Thromb Thrombolysis; 2015 Jan; 39(1):1-7. PubMed ID: 25085573 [TBL] [Abstract][Full Text] [Related]
31. Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI. Angiolillo DJ; Franchi F; Waksman R; Sweeny JM; Raveendran G; Teng R; Zhao Y; Carlson G; Khan N; Mehran R J Am Coll Cardiol; 2016 Feb; 67(6):603-613. PubMed ID: 26868683 [TBL] [Abstract][Full Text] [Related]
32. Ticagrelor vs clopidogrel followed by ticagrelor re-loading in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A randomized, pharmacodynamic comparison. Alexopoulos D; Kontoprias K; Gkizas V; Karanikas S; Ziakas A; Barampoutis N; Tsigkas G; Koutsogiannis N; Davlouros P; Patsilinakos S; Karvounis H; Hahalis G; Xanthopoulou I Platelets; 2016 Jul; 27(5):420-6. PubMed ID: 26763727 [TBL] [Abstract][Full Text] [Related]
33. P2Y Ortega-Paz L; Bor W; Franchi F; van den Broek WWA; Rollini F; Giordano S; Galli M; Been L; Ghanem G; Shalhoub A; Garabedian H; Al Saleh T; Uzunoglu E; Zhou X; Rivas A; Pineda AM; Suryadevara S; Soffer D; Mahowald MK; Choi CY; Zenni MM; Phoenix F; Ajjan RA; Ten Berg JM; Angiolillo DJ JACC Cardiovasc Interv; 2024 Jun; 17(11):1356-1370. PubMed ID: 38597172 [TBL] [Abstract][Full Text] [Related]
34. Fentanyl Delays the Platelet Inhibition Effects of Oral Ticagrelor: Full Report of the PACIFY Randomized Clinical Trial. Ibrahim K; Shah R; Goli RR; Kickler TS; Clarke WA; Hasan RK; Blumenthal RS; Thiemann DR; Resar JR; Schulman SP; McEvoy JW Thromb Haemost; 2018 Aug; 118(8):1409-1418. PubMed ID: 29972861 [TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y Franchi F; Rollini F; Faz G; Rivas JR; Rivas A; Agarwal M; Briceno M; Wali M; Nawaz A; Silva G; Shaikh Z; Maaliki N; Fahmi K; Been L; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Baber U; Mehran R; Jennings LK; Bass TA; Angiolillo DJ J Am Heart Assoc; 2020 Apr; 9(8):e015865. PubMed ID: 32306797 [TBL] [Abstract][Full Text] [Related]
36. Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial. Kubica J; Adamski P; Ostrowska M; Koziński M; Obońska K; Laskowska E; Obońska E; Grześk G; Winiarski P; Paciorek P Trials; 2015 Apr; 16():198. PubMed ID: 25925591 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of P2Y12 receptor antagonists on platelet function and clinical outcomes in patients undergoing Primary PCI: A substudy of the HEAT-PPCI trial. Shahzad A; Khanna V; Kemp I; Shaw M; Mars C; Cooper R; Wilson K; Curzen N; Stables RH EuroIntervention; 2018 Mar; 13(16):1931-1938. PubMed ID: 29336311 [TBL] [Abstract][Full Text] [Related]
38. Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry. Christ G; Siller-Matula JM; Francesconi M; Dechant C; Grohs K; Podczeck-Schweighofer A BMJ Open; 2014 Oct; 4(10):e005781. PubMed ID: 25361837 [TBL] [Abstract][Full Text] [Related]
39. Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study. Bernlochner I; Mayer K; Orban M; Morath T; Jaitner J; Rössner L; Gross L; Laugwitz KL; Kastrati A; Sibbing D Platelets; 2016 Dec; 27(8):796-804. PubMed ID: 27275651 [TBL] [Abstract][Full Text] [Related]
40. Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trial. Kim JS; Han DC; Jeong YH; Park DW; Sohn CB; Hwang KW; Lee SH; Choi JH; Chon MK; Lee SY; Hwang J; Kim IS; Lee SM; Han J; Noh M; Kim CH; Chun KJ; Park YH; Kim JH Thromb Haemost; 2016 Jan; 115(1):213-21. PubMed ID: 26581884 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]